Anika Therapeutics ANIK Amortization Of Acquisition Related Intangible Assets
Amortization Of Acquisition Related Intangible Assets at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept anik:AmortizationOfAcquisitionRelatedIntangibleAssets.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's amortization of acquisition related intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's amortization of acquisition related intangible assets?
- Anika Therapeutics (ANIK) reported amortization of acquisition related intangible assets of $0 in Q1 2026.
- How has Anika Therapeutics's amortization of acquisition related intangible assets changed year-over-year?
- Anika Therapeutics's amortization of acquisition related intangible assets decreased by 100.0% year-over-year, from $209K to $0.
- What is the long-term trend for Anika Therapeutics's amortization of acquisition related intangible assets?
- Over 4 years (2021 to 2025), Anika Therapeutics's amortization of acquisition related intangible assets has grown at a -53.8% compound annual growth rate (CAGR), from $7.84M to $357K.
- What does amortization of acquisition related intangible assets mean?
- This represents the non-cash expense allocated to the reduction of the carrying value of intangible assets acquired through business combinations, such as patents or customer relationships. It reflects the systematic consumption of the economic benefits derived from these acquired assets over their estimated useful lives. Investors monitor this to distinguish between operational performance and the accounting impact of past M&A activity.